A new CISA portal includes the ability to save and update reports and share submitted reports with colleagues or clients for third-party reporting.

Reduced risk for Alzheimer disease, vascular dementia, and Parkinson disease seen with SGLT2i use in type 2 diabetes. (HealthDay News) — For patients with type 2 diabetes, sodium-glucose cotransporter ...

Darolutamide plus androgen deprivation therapy (ADT), without docetaxel, significantly prolonged radiographic progression-free survival compared with placebo plus ADT in patients with metastatic ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Both Headspace and Silvercloud – mobile apps for mental health – are associated with significant improvements in depression and anxiety.

Trial follow-up data showed no improvement in kidney failure and death risks among blood pressure-lowering strategies for patients with ADPKD.

Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...

70.8% of those who were aware of their hypertension status and met criteria for meds had uncontrolled hypertension ...

Weight reduction at 1 year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

Medicare has a proposed a 2.8% reduction in its Physician Fee Schedule conversion factors that could put a financial squeeze on independent urology practices.

Tirzepatide vs GLP-1 agonists demonstrated superior cardiorenal benefits among patients with type 2 diabetes. Treatment with tirzepatide, compared with glucagon-like peptide 1 (GLP-1) receptor ...

In a poll, more than one-third of medical group practices plan to budget for higher-than-usual increases in compensation for 2025. About 35% of medical group practice leaders expect to budget more ...